Does the New FIGO 2018 Staging System Allow Better Prognostic Differentiation in Early Stage Cervical Cancer? A Dutch Nationwide Cohort Study
The FIGO 2018 staging system was introduced to allow better prognostic differentiation in cervical cancer, causing considerable stage migration and affecting treatment options. We evaluated the accuracy of the FIGO 2018 staging in predicting recurrence free (RFS) and overall survival (OS) compared t...
Main Authors: | Mieke L. G. Ten Eikelder, Floor Hinten, Anke Smits, Maaike A. Van der Aa, Ruud L. M. Bekkers, Joanna IntHout, Hans H. B. Wenzel, Petra L. M. Zusterzeel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/13/3140 |
Similar Items
-
Validation of the 2018 FIGO Staging System of Cervical Cancer for Stage III Patients with a Cohort from China
by: Liu X, et al.
Published: (2020-02-01) -
Nomograms Predicting Survival of Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy Based on the 2018 FIGO Staging System
by: Qingyu Meng, et al.
Published: (2022-05-01) -
Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
by: Yanna Ye, et al.
Published: (2023-05-01) -
Influence of New FIGO 2018 Staging on Treatment Outcomes in Early-Stage Cervical Cancer: A Single-Center Study
by: Satinder Kaur, et al.
Published: (2022-07-01) -
FIGO 2018 Staging for Cervical Cancer: Influence on Stage Distribution and Outcomes in the 3D-Image-Guided Brachytherapy Era
by: Kento Tomizawa, et al.
Published: (2020-07-01)